InvestorsHub Logo
Post# of 216677
Next 10
Followers 971
Posts 382978
Boards Moderated 18
Alias Born 06/24/2011

Re: None

Wednesday, 09/20/2017 1:06:39 PM

Wednesday, September 20, 2017 1:06:39 PM

Post# of 216677
$PSID “The reason why this is important is because whenever we experience the beginnings of an outbreak, such as Zika, Ebola, influenza or any other biohazard, rapid identification of who is or isn’t infected is crucial to delivering proper treatment and minimizing the spread of an infectious disease. But one of the biggest barriers to delivering rapid care is (and always has been) preparing samples so they can be tested, quickly and accurately. And this is especially a problem in the field at the Point-of-Care/Point-of-Need. This is the issue we address with our new FireflyDX technologies.” Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says Lyle Probst During BioWatch Panel
https://finance.yahoo.com/news/internal-sample-preparation-small-size-120000072.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.